| Literature DB >> 31525474 |
Michela Rossi1, Paola Sabrina Buonuomo2, Giulia Battafarano1, Antonella Conforti3, Eda Mariani4, Mattia Algeri3, Simone Pelle5, Matteo D'Agostini6, Marina Macchiaiolo2, Rita De Vito7, Michaela Veronika Gonfiantini2, Alessandro Jenkner8, Ippolita Rana2, Andrea Bartuli2, Andrea Del Fattore9.
Abstract
Gorham-Stout disease (GSD) is a rare disorder characterized by progressive osteolysis and angiomatous proliferation. Since the mechanisms leading to bone loss in GSD are not completely understood, we performed histological, serum, cellular and molecular analyses of 7 patients. Increased vessels, osteoclast number and osteocyte lacunar area were revealed in patients' bone biopsies. Biochemical analysis of sera showed high levels of ICTP, Sclerostin, VEGF-A and IL-6. In vitro experiments revealed increased osteoclast differentiation and activity, and impaired mineralization ability of osteoblasts. To evaluate the involvement of systemic factors in GSD, control cells were treated with patients' sera and displayed an increase of osteoclastogenesis, bone resorption activity and a reduction of osteoblast function. Interestingly, GSD sera stimulated the vessel formation by endothelial cells EA.hy926. These results suggest that bone cell autonomous alterations with the cooperation of systemic factors are involved in massive bone loss and angiomatous proliferation observed in GSD patients.Entities:
Keywords: Bone histomorphometry; Gorham-Stout disease; Osteoblast; Osteoclast; Osteolysis
Mesh:
Year: 2019 PMID: 31525474 DOI: 10.1016/j.bone.2019.115068
Source DB: PubMed Journal: Bone ISSN: 1873-2763 Impact factor: 4.398